Phil Tennant - 23 Aug 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Reporting relationship: Chief Commercial Officer
Issuer ticker: PGEN
Reported as of: 23 Aug 2026
Net transaction value: -$593,745
SEC form: 4
Accepted by SEC: 25 Aug 2026, 17:25:38 UTC
Prior SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Phil Tennant, by Donald P. Lehr, as attorney-in-fact

Key filing fact

Phil Tennant filed Form 4 for PRECIGEN, INC. (PGEN) on 25 Aug 2026.

Key facts

This page summarizes Phil Tennant's Form 4 filing for PRECIGEN, INC. (PGEN).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 25 Aug 2026, 17:25.

Change

Previous filing in this sequence was filed on 01 Jun 2026.
Current net transaction value: -$593,745.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002030874 Primary reporting owner

Tennant Phil

Relationship: Chief Commercial Officer
Address: 20374 SENECA MEADOWS PARKWAY, GERMANTOWN
Signature: /s/ Phil Tennant, by Donald P. Lehr, as attorney-in-fact
Signature date: 25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGEN transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,208
Change %: +3.7%
Price
Shares after: 144,577
Date: 23 Aug 2026
Ownership: Direct
Footnotes: F1

PGEN transaction

Common Stock

Tax liability

Transaction value
Shares: -2,585
Change %: -1.8%
Price: $7.20^*
Shares after: 141,992
Date: 23 Aug 2026
Ownership: Direct
Footnotes: F2

PGEN transaction

Common Stock

Options Exercise

Transaction value
Shares: +79,166
Change %: +56%
Price: $1.61^*
Shares after: 221,158
Date: 25 Aug 2026
Ownership: Direct

PGEN transaction

Common Stock

Sale

Transaction value: $593,745
Shares: -79,166
Change %: -36%
Price: $7.50
Shares after: 141,992
Date: 25 Aug 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGEN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -5,208
Change %: -8.3%
Price: $0.000000^*
Shares after: 57,292
Date: 23 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,208
Exercise price
Footnotes: F1, F4

PGEN transaction Derivative

Option to Purchase Common Stock (Right to Buy)

Options Exercise

Transaction value
Shares: -79,166
Change %: -40%
Price: $0.000000^*
Shares after: 120,834
Date: 25 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 79,166
Exercise price: $1.61
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

Footnote F2

Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.

Footnote F3

Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.

Footnote F4

Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.

Footnote F5

The stock options vested 25% on July 22, 2025 and in equal monthly installments for three years thereafter.